http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5c6c8dc1681f636bd2f47d6401ae31f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Kirn H. Kirn |
| name | David H. Kirn David H Kirn |
| given-name | David H David David H. |
| organization-name | 2Ignite Immunotherapy, Alameda, California. Jennerex Inc., 450 Sansome Street, 16th Floor, San Francisco, CA 94111, USA. The authors are with ONYX Pharmaceuticals, 3031 Research Drive, Richmond, CA 94806, USA. Imperial Cancer Research Fund and Imperial College School of Medicine, Hammersmith Hospital, W12 0NN, London, UK Onyx Pharmaceuticals Jennerex Biotherapeutics Inc.and Department of Clinical Pharmacology, University of Oxford, San Francisco,Oxford, CA,UK Authors' Affiliations: 1Jennerex Inc., San Francisco, California; 2Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa; 3Department of Biochemistry, University of Ottawa, Ontario, Canada; 4Departments of Surgery and Immunology, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania; 5RadMD, Doylestown, Pennsylvania; 6Pusan National University, Busan, South Korea, 7Experimental Therapeutics, Toronto General Research Institute, University Health Network; and 8Department of Surgery, University of Toronto, Toronto, Ontario, Canada. 1Jennerex Biotherapeutics, Ltd., San Francisco, California; 3SillaJen Biotherapeutics Inc., San Francisco, California. Authors' Affiliations: 1Centre for Innovative Cancer Research, Ottawa Hospital Research Institute; Departments of 2Biochemistry, Microbiology, and Immunology, and 3Surgery, University of Ottawa, Ottawa, Ontario, Canada; and 4Jennerex Inc., San Francisco, California Kirn Oncology Consulting, 94941, Mill Valley, CA, USA;Department of Pharmacology, Oxford University Medical School, OX2 6HE, Oxford, UK Department of Pharmacology, Oxford University Medical School |
Incoming Links
Showing number of triples: 1 to 77 of 77.